TheProfitWatch

NBIX - Neurocrine Biosciences Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
137.19 0.53 (0.39%) --- --- --- --- 0.53 (0.39%) --- ---

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
1.09
Diluted EPS:
1.06
Basic P/E:
126.3486
Diluted P/E:
129.9245
RSI(14) 1m:
22.8
VWAP:
137.79
RVol:
0.5808

Events

Period Kind Movement Occurred At

Related News